益赛普治疗风湿免疫疾病的临床效果.docVIP

精品论文 参考文献 益赛普治疗风湿免疫疾病的临床效果 万琦 　　【摘 要】 目的 探究益赛普对风湿免疫疾病的治疗效果。方法 选取本院2013年3月~2015年7月收治的96例风湿免疫疾病患者，并分为2组。对照组采用常规药物治疗，观察组在常规药物基础上加用益赛普治疗。并对两组患者的治疗效果、并发症情况、红细胞沉降率与C反应蛋白水平变化情况对比分析。 结果 观察组患者的总有效率高于对照组（97.92% VS 75%），（Plt;0.05）；与治疗前相比，两组患者治疗后的红细胞沉降率与C反应蛋白水平均有明显的降低，且观察组患者的下降幅度明显高于对照组（Plt;0.05）；两组不良反应的对比（Pgt;0.05）。结论 益赛普在风湿免疫疾病中的应用效果显著，免疫性较低，耐受性较好。 　　【关键词】 益赛普； 风湿免疫疾病； 临床效果 　　The clinical effect of Etanercept on rheumatism IMD treatment. Qi Wang. Department of Rheumatology,Jingzhou Central Hospital,Jingzhou,Hubei Province, 434020, China 　　【Abstract】 Objective explore the clinical effect of Etanercept on rheumatism IMD treatment. Method 96 rheumatism IMD patients received from March 2013 to July 2015 in ouc hospital are selected and divided into two groups. The control group is applied with conventional medicine treatment, and observation group are treated additional with Etanercept on the basis of conventional medicine treatment. Then make the contrastive analysis on treatment effect, complication condition, erythrocyte sedimentation rate and C-reactive protein variation level of patients in two groups. Result Patients in the observation group have higher total effective rate than the control group (97.92% VS 75%), (Plt;0.05); compared with pre-treatment, patientsrsquo; after-treatment erythrocyte sedimentation rate and C-reactive protein variation level have obviously decreased, and patients in the observation group has higher falling range than control group (Plt;0.05); contrast on untoward effect in two groups (Pgt;0.05).Conclusion Etanercept has a significant application effect in rheumatism IMD treatment with low immunity and good tolerance. 　　【Keywords】 Etanercept; rheumatism IMD; clinical effect 　　风湿免疫疾病属于医院内科疾病领域中的一些列疾病的统称，主要包括类风湿性关节炎、原发性干燥综合征、强直性脊柱炎、系统性红斑狼疮、通风和骨关节炎等。风湿免疫疾病的病因复杂、多样，意外创伤、体弱多病、遗传因素、药物因素、感染因素、居住环境潮湿等都可能导致病人患有风湿免疫疾病[1]。这类疾病常表现出对关节、骨骼、肌肉及关节周围组织的侵犯，给患者带来巨大痛苦。本文以风湿免疫疾病中的类风湿性关节炎的治疗为例，探究益赛普在治疗风湿免疫疾病中的临床效果。报告如下： 　　资料与方法 　　1.一般资料 　　选取本院2013年3